BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18691001)

  • 1. Bone effects of glitazones and other anti-diabetic drugs.
    Rejnmark L
    Curr Drug Saf; 2008 Sep; 3(3):194-8. PubMed ID: 18691001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies.
    Hidayat K; Du X; Wu MJ; Shi BM
    Obes Rev; 2019 Oct; 20(10):1494-1503. PubMed ID: 31250977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of fractures with glitazones: a critical review of the evidence to date.
    Bodmer M; Meier C; Kraenzlin ME; Meier CR
    Drug Saf; 2009; 32(7):539-47. PubMed ID: 19530741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health in diabetes: considerations for clinical management.
    Adami S
    Curr Med Res Opin; 2009 May; 25(5):1057-72. PubMed ID: 19292601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture risk associated with common medications used in treating type 2 diabetes mellitus.
    Wolverton D; Blair MM
    Am J Health Syst Pharm; 2017 Aug; 74(15):1143-1151. PubMed ID: 28743778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
    Scheen AJ
    Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies.
    Adil M; Khan RA; Kalam A; Venkata SK; Kandhare AD; Ghosh P; Sharma M
    Pharmacol Rep; 2017 Dec; 69(6):1328-1340. PubMed ID: 29132091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thiazolidinediones on BMD and osteoporosis.
    McDonough AK; Rosenthal RS; Cao X; Saag KG
    Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):507-13. PubMed ID: 18695700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic therapy effects on bone metabolism and fracture risk.
    Montagnani A; Gonnelli S
    Diabetes Obes Metab; 2013 Sep; 15(9):784-91. PubMed ID: 23368527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do thiazolidinediones harm skeletal integrity?].
    Takeuchi Y
    Clin Calcium; 2008 May; 18(5):650-5. PubMed ID: 18445884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes increases the risk of fractures].
    Starup-Linde J; Karahasanovic A; Vestergaard P; Eiken P
    Ugeskr Laeger; 2015 Nov; 177(49):V08150663. PubMed ID: 26651553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What to add in with metformin in type 2 diabetes?
    Petrie JR; Adler A; Vella S
    QJM; 2011 Mar; 104(3):185-92. PubMed ID: 21156663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    Hippisley-Cox J; Coupland C
    BMJ; 2016 Jul; 354():i3477. PubMed ID: 27413012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinedione use and the risk of fractures.
    Reblin T
    CMAJ; 2009 Apr; 180(8):841. PubMed ID: 19364797
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes and bone fragility: a dangerous liaison.
    Conti F; Wolosinska DT; Pugliese G
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S39-41. PubMed ID: 23907773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antidiabetic drugs and their effect on bone].
    Jackuliak P; Kužma M; Payer J
    Vnitr Lek; 2017; 63(9):609-616. PubMed ID: 29120659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.